D. Diamond

发表

Mapping Neutralization Domains of Viruses

E. Wimmer, E. Emini, A. EminiEmilio, 1986 .

Recombinants of Mahoney and Sabin strain poliovirus type 1: analysis of in vitro phenotypic markers and evidence that resistance to guanidine maps in the nonstructural proteins.

E. Wimmer, E. Emini, D. Diamond, 1984, Virology.

Antigen-targeted, synthetic vaccines for metastatic cancer

T. Kündig, A. Bot, D. Diamond, 2011 .

Intra–Lymph Node Prime-Boost Vaccination against Melan A and Tyrosinase for the Treatment of Metastatic Melanoma: Results of a Phase 1 Clinical Trial

S. Raman, A. Ribas, J. Weber, 2011, Clinical Cancer Research.

A Phase 1 Study of a Vaccine Targeting Preferentially Expressed Antigen in Melanoma and Prostate-specific Membrane Antigen in Patients With Advanced Solid Tumors

J. Marshall, M. Ernstoff, N. Vogelzang, 2011, Journal of immunotherapy.

Enhancing DNA vaccination by sequential injection of lymph nodes with plasmid vectors and peptides.

T. Kündig, A. Bot, D. Diamond, 2009, Vaccine.

Inhibition of CD4+ T cell function by the HIV envelope protein, gp120.

L. Lasky, D. Diamond, B. Sleckman, 1988, Journal of immunology.

Prevention of HIV-1 infection and preservation of CD4 function by the binding of CPFs to gp120.

S. Schreiber, R. Finberg, D. Diamond, 1990, Science.

T cell hybridomas define the class II MHC-restricted response to vesicular stomatitis virus infection.

D. Faller, D. Diamond, S. Burakoff, 1988, Microbial pathogenesis.

High level of surface CD4 prevents stable human immunodeficiency virus infection of T-cell transfectants

R. Finberg, D. Diamond, M. Kowalski, 1992, Journal of virology.

Guanidine-selected mutants of poliovirus: mapping of point mutations to polypeptide 2C

E. Wimmer, E. Emini, S. Pincus, 1986, Journal of virology.

Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site

R. Crainic, B. Blondel, F. Horaud, 1986, Journal of virology.

Antigenic variation and resistance to neutralization in poliovirus type 1.

S. Kuge, A. Nomoto, M. Kohara, 1985, Science.

Structure, Proteolytic Processing, and Neutralization Antigenic Sites of Poliovirus

B. Semler, E. Wimmer, R. Hanecak, 1984 .

Human immunodeficiency virus infection is efficiently mediated by a glycolipid-anchored form of CD4.

S. Chaudhuri, R. Finberg, D. Diamond, 1990, Proceedings of the National Academy of Sciences of the United States of America.